Evidence map›Paper›PMID 35597947›Full record

Trial reportBMC health services research2022

Patient navigator team perceptions on the implementation of a citywide breast cancer patient navigation protocol: a qualitative study.

Stephanie Loo, Katelyn Mullikin, Charlotte Robbins, Victoria Xiao, Tracy A Battaglia, Stephenie C Lemon, Christine Gunn, TRIP Consortium

Registry-linked trialOpen access · goldAbstract readMulticenter StudyPragmatic Clinical Trial
In one paragraph

Trial report in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03514433 (Translating Research Into Practice), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03514433 nacompletednot on this map

Translating Research Into Practice: A Regional Collaborative to Reduce Disparities in Breast Cancer Care

TypeinterventionalSponsorBoston Medical CenterRan2016 to 2023Enrolled1,725ConditionsCancer, BreastArmsTRIP Patient Navigation Intervention
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Stephanie LooDepartment of Health Law, Policy, and Management, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA. ssloo@bu.edu.
Katelyn MullikinWomen's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Charlotte RobbinsWomen's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Victoria XiaoWomen's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Tracy A BattagliaWomen's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Stephenie C LemonUniversity of Massachusetts Chan Medical School, Worcester, MA, USA.
Christine GunnDepartment of Health Law, Policy, and Management, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
TRIP Consortium
Boston Medical Center · USBoston University · USUniversity of Massachusetts Chan Medical School · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
University of Massachusetts Center for Clinical Science and Translational SupplementUL1TR001453 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2015 to 2024
$39.0M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
Translating Research Into Practice: A Regional Collaborative to Reduce Disparities in Breast Cancer CareU01TR002070 · NCATS · BOSTON MEDICAL CENTER · PI BATTAGLIA, TRACY ANN, FREUND, KAREN · 2017 to 2021
$8.7M
Training in Health Services Research for Vulnerable PopulationsT32HS022242 · AHRQ · BOSTON MEDICAL CENTER · PI LAROCHELLE, MARC · 2013 to 2024
$4.1M
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy WomenK07CA221899 · NCI · DARTMOUTH COLLEGE · PI GUNN, CHRISTINE MARIE · 2018 to 2022
$642k
AHRQ HHS 2T32HS022242AHRQ HHS T32 HS022242National Cancer Research Institute K07CA221899NCATS NIH HHS U01 TR002070NCATS NIH HHS U01TR002070NCATS NIH HHS UL1 TR000170NCATS NIH HHS UL1 TR001430NCATS NIH HHS UL1 TR001453NCATS NIH HHS UL1 TR002544NCI NIH HHS K07 CA221899
6 · The paper itself

Abstract

backgroundIn 2018 Translating Research Into Practice (TRIP), an evidence-based patient navigation intervention aimed at addressing breast cancer care disparities, was implemented across six Boston hospitals. This study assesses patient navigator team member perspectives regarding implementation barriers and facilitators one year post-study implementation.

methodsWe conducted in-depth qualitative interviews at the six sites participating in the pragmatic TRIP trial from December 2019 to March 2021. Navigation team members involved with breast cancer care navigation processes at each site were interviewed at least 12 months after intervention implementation. Interview questions were designed to address domains of the Consolidated Framework for Implementation Research (CFIR), focusing on barriers and facilitators to implementing the intervention that included 1) rigorous 11-step guidelines for navigation, 2) a shared patient registry and 3) a social risk screening and referral program. Analysis was structured using deductive codes representing domains and constructs within CFIR.

resultsSeventeen interviews were conducted with patient navigators, their supervisors, and designated clinical champions. Participants identified the following benefits provided by the TRIP intervention: 1) increased networking and connections for navigators across clinical sites (Cosmopolitanism), 2) formalization of the patient navigation process (Goals and Purpose, Access to Knowledge and Information, and Relative Advantage), and 3) flexibility within the TRIP intervention that allowed for diversity in implementation and use of TRIP components across sites (Adaptability). Barriers included those related to documentation requirements (Complexity) and the structured patient follow up guidelines that did not always align with the timeline of existing site navigation processes (Relative Priority).

conclusionsOur analysis provides data using real-world experience from an intervention trial in progress, identifying barriers and facilitators to implementing an evidence-based patient navigation intervention for breast cancer care. We identified core processes that facilitated the navigators' patient-focused tasks and role on the clinical team. Barriers encountered reflect limitations of navigator funding models and high caseload.

trial registrationClinical Trial Registration Number NCT03514433 , 5/2/2018.

Indexed as

Breast NeoplasmsPatient NavigationBostonFemaleHumansQualitative ResearchReferral and ConsultationBreast cancer careCFIRPatient navigationSocial risk screenings

Identifiers

PMID35597947
PMCPMC9123866
OpenAlexW4281261642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.